KATHRINE CECIL: Open Payments
NPI 1376767319 · NASHUA, NH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,302 in 68 payments from 15 companies in 2025. Trend: 2023 $924 · 2024 $2,406 · 2025 $2,302
Food & beverage: $2,035Education: $267
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 14 | $499 |
| GENZYME CORPORATION | 15 | $492 |
| Janssen Biotech, Inc. | 7 | $247 |
| ABBVIE INC. | 10 | $225 |
| Galderma Laboratories, L.P. | 2 | $194 |
| Arcutis Biotherapeutics, Inc. | 6 | $181 |
| LEO Pharma Inc. | 1 | $96 |
| SANOFI-AVENTIS U.S. LLC | 1 | $95 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $72 |
| Amgen Inc. | 3 | $65 |
Products named: Bimzelx, DUPIXENT, TREMFYA, SKYRIZI, NEMLUVIO, Zoryve, ANZUPGO, OTEZLA.
Industry payments across NH — which companies pay providers there.
